Mutations in the CTNNB1 gene can lead to aberrant activation of the Wnt pathway, resulting in uncontrolled cell growth and cancer. Such mutations typically stabilize beta-catenin, preventing its degradation and allowing it to accumulate in the nucleus. This accumulation can lead to the transcription of oncogenes that drive the development of various cancers, including colorectal cancer, liver cancer, and ovarian cancer.
